High-risk women (> 20% lifetime BC risk), including mutation carriers (BRCA1/2, PTEN, TP53, STK11, CDH1, PALB2), and those with chest irradiation before 40, should be offered annual MRI [4, 11–13]. This evidence concerns the gene BRCA1 and breast cancer.